221 related articles for article (PubMed ID: 31278449)
1. Routine RNA sequencing of formalin-fixed paraffin-embedded specimens in neuropathology diagnostics identifies diagnostically and therapeutically relevant gene fusions.
Stichel D; Schrimpf D; Casalini B; Meyer J; Wefers AK; Sievers P; Korshunov A; Koelsche C; Reuss DE; Reinhardt A; Ebrahimi A; Fernández-Klett F; Kessler T; Sturm D; Ecker J; Milde T; Herold-Mende C; Witt O; Pfister SM; Wick W; Jones DTW; von Deimling A; Sahm F
Acta Neuropathol; 2019 Nov; 138(5):827-835. PubMed ID: 31278449
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens.
Haley L; Parimi V; Jiang L; Pallavajjala A; Hardy M; Yonescu R; Morsberger L; Stinnett V; Long P; Zou YS; Gocke CD
J Mol Diagn; 2021 Oct; 23(10):1343-1358. PubMed ID: 34358677
[TBL] [Abstract][Full Text] [Related]
3. Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets.
Sahm F; Schrimpf D; Jones DT; Meyer J; Kratz A; Reuss D; Capper D; Koelsche C; Korshunov A; Wiestler B; Buchhalter I; Milde T; Selt F; Sturm D; Kool M; Hummel M; Bewerunge-Hudler M; Mawrin C; Schüller U; Jungk C; Wick A; Witt O; Platten M; Herold-Mende C; Unterberg A; Pfister SM; Wick W; von Deimling A
Acta Neuropathol; 2016 Jun; 131(6):903-10. PubMed ID: 26671409
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of an RNA Sequencing Assay for Gene Fusion Detection in Formalin-Fixed, Paraffin-Embedded Tumors.
Peng H; Huang R; Wang K; Wang C; Li B; Guo Y; Li M; Zhang D; Dong H; Chen H; Chen C; Xu Q; Li F; Tian L; Wu J
J Mol Diagn; 2021 Feb; 23(2):223-233. PubMed ID: 33271368
[TBL] [Abstract][Full Text] [Related]
5. Formalin-Fixed, Paraffin-Embedded-Targeted Locus Capture: A Next-Generation Sequencing Technology for Accurate DNA-Based Gene Fusion Detection in Bone and Soft Tissue Tumors.
Stelloo E; Meijers RWJ; Swennenhuis JF; Allahyar A; Hajo K; Cangiano M; de Leng WWJ; van Helvert S; Van der Meulen J; Creytens D; van Kempen LC; Cleton-Jansen AM; Bovee JVMG; de Laat W; Splinter E; Feitsma H
J Mol Diagn; 2023 Oct; 25(10):758-770. PubMed ID: 37517473
[TBL] [Abstract][Full Text] [Related]
6. Amplicon-Based Targeted Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Tissue.
Strengman E; Barendrecht-Smouter FAS; de Voijs C; de Vree P; Nijman IJ; de Leng WWJ
Methods Mol Biol; 2019; 1908():1-17. PubMed ID: 30649717
[TBL] [Abstract][Full Text] [Related]
7. Validation of a DNA-Based Next-Generation Sequencing Test for Molecular Diagnostic Variant and Fusion Detection in Formalin-Fixed, Paraffin-Embedded Tissue Specimens and Liquid Biopsy Plasma/Cell-Free DNA Samples.
Werner TV; Kock S; Weber I; Kayser G; Werner M; Lassmann S
J Mol Diagn; 2022 Jul; 24(7):784-802. PubMed ID: 35787794
[TBL] [Abstract][Full Text] [Related]
8. Fusion transcript discovery in formalin-fixed paraffin-embedded human breast cancer tissues reveals a link to tumor progression.
Ma Y; Ambannavar R; Stephans J; Jeong J; Dei Rossi A; Liu ML; Friedman AJ; Londry JJ; Abramson R; Beasley EM; Baker J; Levy S; Qu K
PLoS One; 2014; 9(4):e94202. PubMed ID: 24727804
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors.
Hovelson DH; McDaniel AS; Cani AK; Johnson B; Rhodes K; Williams PD; Bandla S; Bien G; Choppa P; Hyland F; Gottimukkala R; Liu G; Manivannan M; Schageman J; Ballesteros-Villagrana E; Grasso CS; Quist MJ; Yadati V; Amin A; Siddiqui J; Betz BL; Knudsen KE; Cooney KA; Feng FY; Roh MH; Nelson PS; Liu CJ; Beer DG; Wyngaard P; Chinnaiyan AM; Sadis S; Rhodes DR; Tomlins SA
Neoplasia; 2015 Apr; 17(4):385-99. PubMed ID: 25925381
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Oncomine
Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cytocentrifugation supernatant fluid and formalin-fixed paraffin-embedded tissue for targeted next-generation sequencing.
Janaki N; Harbhajanka A; Michael CW; Bomeisl P; Wasman J; Atchley M; Miskiewicz K; Alouani D; Sadri N
Cancer Cytopathol; 2019 May; 127(5):297-305. PubMed ID: 30933438
[TBL] [Abstract][Full Text] [Related]
12. A new generation of cancer genome diagnostics for routine clinical use: overcoming the roadblocks to personalized cancer medicine.
Heuckmann JM; Thomas RK
Ann Oncol; 2015 Sep; 26(9):1830-1837. PubMed ID: 25899787
[TBL] [Abstract][Full Text] [Related]
13. Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases.
Volckmar AL; Leichsenring J; Kirchner M; Christopoulos P; Neumann O; Budczies J; Morais de Oliveira CM; Rempel E; Buchhalter I; Brandt R; Allgäuer M; Talla SB; von Winterfeld M; Herpel E; Goeppert B; Lier A; Winter H; Brummer T; Fröhling S; Faehling M; Fischer JR; Heußel CP; Herth F; Lasitschka F; Schirmacher P; Thomas M; Endris V; Penzel R; Stenzinger A
Int J Cancer; 2019 Aug; 145(3):649-661. PubMed ID: 30653256
[TBL] [Abstract][Full Text] [Related]
14. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
[TBL] [Abstract][Full Text] [Related]
15. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
Heideman DA; Lurkin I; Doeleman M; Smit EF; Verheul HM; Meijer GA; Snijders PJ; Thunnissen E; Zwarthoff EC
J Mol Diagn; 2012; 14(3):247-55. PubMed ID: 22425762
[TBL] [Abstract][Full Text] [Related]
16. HaloPlex Targeted Resequencing for Mutation Detection in Clinical Formalin-Fixed, Paraffin-Embedded Tumor Samples.
Moens LN; Falk-Sörqvist E; Ljungström V; Mattsson J; Sundström M; La Fleur L; Mathot L; Micke P; Nilsson M; Botling J
J Mol Diagn; 2015 Nov; 17(6):729-39. PubMed ID: 26354930
[TBL] [Abstract][Full Text] [Related]
17. A computational tool to detect DNA alterations tailored to formalin-fixed paraffin-embedded samples in cancer clinical sequencing.
Kato M; Nakamura H; Nagai M; Kubo T; Elzawahry A; Totoki Y; Tanabe Y; Furukawa E; Miyamoto J; Sakamoto H; Matsumoto S; Sunami K; Arai Y; Suzuki Y; Yoshida T; Tsuchihara K; Tamura K; Yamamoto N; Ichikawa H; Kohno T; Shibata T
Genome Med; 2018 Jun; 10(1):44. PubMed ID: 29880027
[TBL] [Abstract][Full Text] [Related]
18. Clinical Implications of a Targeted RNA-Sequencing Panel in the Detection of Gene Fusions in Solid Tumors.
Sun L; McNulty SN; Evenson MJ; Zhu X; Robinson JA; Mann PR; Duncavage EJ; Pfeifer JD
J Mol Diagn; 2021 Dec; 23(12):1749-1760. PubMed ID: 34562614
[TBL] [Abstract][Full Text] [Related]
19. A Multiplexed Amplicon Approach for Detecting Gene Fusions by Next-Generation Sequencing.
Beadling C; Wald AI; Warrick A; Neff TL; Zhong S; Nikiforov YE; Corless CL; Nikiforova MN
J Mol Diagn; 2016 Mar; 18(2):165-75. PubMed ID: 26747586
[TBL] [Abstract][Full Text] [Related]
20. An Efficient Method for Identifying Gene Fusions by Targeted RNA Sequencing from Fresh Frozen and FFPE Samples.
Scolnick JA; Dimon M; Wang IC; Huelga SC; Amorese DA
PLoS One; 2015; 10(7):e0128916. PubMed ID: 26132974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
